University of North Carolina at Pembroke professor Dr. Ben Bahr's method for treating Alzheimer's disease and patients with a traumatic brain injury received a patent — the first-ever for the school. | Photo Courtesy of UNC at Pembroke
University of North Carolina at Pembroke professor Dr. Ben Bahr's method for treating Alzheimer's disease and patients with a traumatic brain injury received a patent — the first-ever for the school. | Photo Courtesy of UNC at Pembroke
The Lumberton Chamber of Commerce spotlighted the University of North Carolina at Pembroke for receiving its first patent in the school's history.
UNC Pembroke's patent deals with treating Alzheimer's disease and patients who had a traumatic brain injury.
"This is exciting news for the university," the Lumberton Chamber of Commerce said in the Aug. 26 release, "but more importantly for the worldwide efforts to slow and even reverse the progression of Alzheimer's disease."
The university's patent was spearheaded by Dr. Ben Bahr, chairman of the William C. Friday, and his team from UNC Pembroke Biotechnology Center.
"The patent covers previous compounds, new derivatives, and unique combinations that tap into the rapidly growing field of natural products for brain health," Bahr said, a molecular biology and biochemistry professor, said in an Aug. 24 release from UNC Pembroke. "We are probably the first to show how you can combine them to be able to treat diseases such as Alzheimer's, Huntington's disease and ALS."
Alerts Sign-up